Tag: Choroideremia

Gene therapy company 4D Molecular Therapeutics raises $70m in Series C round

pharmanewsdaily- June 17, 2020

California-based gene therapy company 4D Molecular Therapeutics (4DMT), which is focused on adeno-associated virus (AAV) gene therapy vector discovery and product development, has raised $70 ... Read More

Gene therapy company 4D Molecular Therapeutics raises $90m in new funding

pharmanewsdaily- September 6, 2018

California-based gene therapy company 4D Molecular Therapeutics (4DMT), which is focused on adeno-associated virus (AAV) gene therapy vector discovery and product development, has raised $90 ... Read More